Product NDC: | 0527-1726 |
Proprietary Name: | Ondansetron Hydrochloride |
Non Proprietary Name: | Ondansetron Hydrochloride |
Active Ingredient(s): | 2 mg/mL & nbsp; Ondansetron Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0527-1726 |
Labeler Name: | Lannett Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090116 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100701 |
Package NDC: | 0527-1726-40 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0527-1726-40) > 20 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0527-1726-40 |
Proprietary Name | Ondansetron Hydrochloride |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0527-1726-40) > 20 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0527-1726 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ondansetron Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100701 |
Marketing Category Name | ANDA |
Labeler Name | Lannett Company, Inc. |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |